U.S. says two Indian nationals indicted in counterfeit Ozempic smuggling scheme

Between July 2023 and April 2024, Swapnadip Roy and Vicky Ramancha allegedly obtained counterfeit Ozempic in China and sold it to U.S. distributors at discounted prices, Justice Department said

A U.S. federal grand jury has indicted two Indian nationals for ​allegedly smuggling and selling counterfeit ⁠Ozempic, the weight-loss drug, the Department of Justice said on Tuesday (September 29, 2026). One of the defendants, ‌Swapnadip Roy, pleaded not guilty after being extradited from Italy ‌, while the other, Vicky Ramancha, ‌remains ⁠at large, the department said.

Between ⁠July 2023 and April 2024, Mr. Roy and Mr. Ramancha allegedly obtained counterfeit Ozempic in China ​and sold it ‌to U.S. distributors at discounted prices, it said.

A legal representative for Mr. Roy did not immediately respond to ‌a request for comment. One ​for Mr. Ramancha was not immediately available.

The counterfeit medication included packaging, ⁠inserts, and labels allegedly meant to convince purchasers that they were receiving authentic ‌Ozempic, the popular weight-loss drug that can cost hundreds of dollars per month for patients. “The scheme continued even after the FDA seized some of the counterfeit Ozempic in ‌December 2023 and issued a public ​warning regarding the products,” the Justice Department said.

Mr. Roy and Mr. Ramancha ⁠were charged with smuggling and selling counterfeit drugs, conspiracy to commit smuggling and to defraud the United States. ‌They face up to 71 years in prison if convicted.

  • Related Posts

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels